Drescher C

No ORCID on file · 2 papers in corpus · active 2004-2008
2008
Gynecologic Oncology ·doi:10.1016/j.ygyno.2008.07.036

ObjectivesTo define patterns of aberrant DNA methylation, p53 mutation and Her-2/neu overexpression in tissues from benign (n=29), malignant (n=100), and border line malignant ovaries (n=10), as compared to normal (n=68) ovarian tissues. Fu…

2004
Gynecologic Oncology ·doi:10.1016/j.ygyno.2004.07.039

ObjectivesThe serum tumor marker CA 125 is elevated in most clinically advanced ovarian carcinomas. Because these elevations may precede clinical detection by a year or more, CA 125 is potentially useful for early detection as part of an ov…